Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

AstraZeneca Pharma India bags CDSCO nod for expanded use of Trastuzumab Deruxtecan in HER2-Positive Solid Tumors

Ruchika Sharma7 Oct 2025 2:51 PM IST

Bangalore: AstraZeneca Pharma India Limited has received approval from the Central Drugs Standard Control Organisation (CDSCO) to import,...

Himachal, UP Join States Banning Coldrif Cough Syrup After MP Deaths

Coldrif Cough Syrup banned in Punjab amid child deaths

Ruchika Sharma7 Oct 2025 2:00 PM IST

Chandigarh: The Punjab government has taken swift action to ban the sale, distribution, and use of Coldrif cough syrup following the tragic...

Contaminated cough syrup tragedy: NHRC steps in, demands investigation

Ruchika Sharma7 Oct 2025 1:00 PM IST

New Delhi: The National Human Rights Commission (NHRC) has issued a call to action, demanding an investigation into the alleged deaths of...

DoP identifies 11,100 Jan Aushadhi Kendras across India as Outdoor Cleaning Sites

Ruchika Sharma7 Oct 2025 12:09 PM IST

New Delhi: As part of the Special Campaign for Disposal of Pending Matters (SCDPM) 5.0, the Department of Pharmaceuticals (DoP) has identified...

Biocon Pharma, Carnegie Pharma gain USFDA tentative nod for Rifaximin Tablets to treat irritable bowel syndrome with diarrhea

Ruchika Sharma7 Oct 2025 10:57 AM IST

Bangalore: Biocon has announced that Biocon Pharma Limited, a wholly owned subsidiary of the Company, in partnership with Carnegie...

Eli Lilly plans to invest over USD 1 billion in new contract manufacturing in India

Ruchika Sharma7 Oct 2025 10:15 AM IST

Mumbai: Eli Lilly and Company has announced plans to invest more than USD 1 billion over the next several years into new contract manufacturing...

Zydus Gets CDSCO Panel Nod to Market Sodium Chloride Nebuliser Solution

Zydus Lifesciences gets NOC from Health Canada for hypothyroidism tablets

Ruchika Sharma6 Oct 2025 4:46 PM IST

Ahmedabad: Zydus Lifesciences Limited has received NOC (Notice of Compliance) from Health Canada for generic Liothyronine tablets 5 mcg and 25...

Zydus Liesciences secures USFDA okay for Duchenne Muscular Dystrophy drug

Zydus Lifesciences secures USFDA okay for Duchenne Muscular Dystrophy drug

Ruchika Sharma6 Oct 2025 3:45 PM IST

Ahmedabad: Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA) for Deflazacort ...

Coldrif Syrup banned in Maharashtra after child deaths

MD Bureau6 Oct 2025 2:15 PM IST

Mumbai: In a sweeping move to protect public health, the Maharashtra Food and Drugs Administration (FDA) has ordered to immediately stop the...

Inside Coldrif Scandal: Tamil Nadu Plant Used Paint-Grade Chemicals, Violated 300+ Drug Norms

Sensitise public on alert against Coldrif cough syrup batch: Telangana govt directs health officials

Ruchika Sharma6 Oct 2025 1:15 PM IST

Hyderabad: The Director of Public Health, Telangana, has instructed all District Medical and Health Officers (DM&HOs) to actively sensitise...

Bristol Myers Squibb BMS 986446 granted fast track designation by USFDA for Alzheimer

Bristol Myers Squibb BMS 986446 gets USFDA fast track designation for Alzheimer's Disease

Ruchika Sharma6 Oct 2025 12:15 PM IST

Princeton: Bristol Myers Squibb has announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to BMS-986446,...

Union Health Secretary chairs high level meeting with States, UTs on quality, rational use of cough syrups

Ruchika Sharma6 Oct 2025 11:02 AM IST

The Union Health Secretary emphasized strict compliance with the Revised Schedule M by all drug manufacturers.

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok